Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival. [electronic resource]
Producer: 20081008Description: 5884-92 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Antigens, CD1 -- metabolism
- Carcinoma, Renal Cell -- drug therapy
- Cell Lineage
- Dendritic Cells -- immunology
- Disease-Free Survival
- Female
- Glycoproteins -- metabolism
- Humans
- Indoles -- pharmacology
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Myeloid Cells -- immunology
- Pyrroles -- pharmacology
- Sunitinib
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.